chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccines 1.26.15 approx 8:15 AM. At noon that day pt's mother was notified by school patient crying due to headache. Treated with TYLENOL without significant relief. Headache continued next 3 days without significant relief. Missed school of Wednesday. Headache resolved by Friday. Mother states pt had never had a severe headache ever before.
4-5 raised red patches with clusters of blisters on extremities. They appeared similar to severe patches of eczema, except that the bumps appeared to be small blisters. I administered over the counter eczema cream. Following day, very small blisters were all over, the raised patches with clusters were more pronounced. Small individual blisters were covering the backs of her legs and feet. There were one or two on her fingers. Her torso and arms had very tiny bumps not quite blistering similar to mild case of eczema. Treated with warm bath and Benadryl. Doctor was called and reported he said to bring her in Monday which would be the following day. By the third day all the blisters appeared to be healing. No blisters were ever torn open and she did not appear too bothered by the blisters other than a little rubbing at her feet, which were covered in the tiny bumps.
24y/o male with remote history of Kawasaki disease fevers, chills, night sweats, anorexia, nausea, vomiting, dehydration, chest pain, dyspnea, constipation. Symptoms began around 1600 on 27JAN21 (day of immunization). Worsened on 28JAN21. On 29JAN21 presented to primary care with tachycardia prompting IV fluid resuscitation.
New onset Atrial Fibrillation requiring cardioversion. No family history or prior history of atrial fibrillation. Cardiac echo normal. Troponins, TSH, and other labs normal.
2-11-2009 SWOLLEN GLANDS, DIZZINESS, UNBALANCE, FEVER, HONE PAIN.  CALLED US ON 2-23-2009 NOW SHE HAS DIFFICULTY BREATHING, HOUSE (SP?) RASH, PALENESS, WAKNESS, AND HIVES, HER HEART BEAT IS ICNREASED.  ASKED HER TO PLEASE SEE A DOCTOR 2/24/2009
I had eyes watery; cough; runny nose; headache; fever; ache in bones; and sneezing for five days. Doctor gave me IV for symptoms and I started  feeling better.
Client complained of waking up with a rash on her left hip, thigh and left arm on 10-21-03. Client went in to see her private doctor on 10-23-03. She was instructed to get over the counter Benadryl and return in two weeks if rash didn't resolve. Client continues to have rash. Client plans to follow up.
No additional adverse events reported; the student had received MMRV/PROQUAD; the student is missing their MMR; This spontaneous report was received from a nurse referring to her student of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 18-SEP-2008, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # reported as 0392X but upon internal validation established as  660654/0392X, expiration date was reported as unknown, but upon internal validation established as  05-MAR-2010, 0.5 milliliter) subcutaneously for prophylaxis.    The patient was missing the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (0.5 ml, subcutaneous; strength, lot# and expiration date were not reported) vaccine on the document (product dose omission issue). It was reported that the dose of varicella virus vaccine live (oka/merck)(VARIVAX) should have been received with the vaccine of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) on the same date. It was unknown if documented incorrectly and the patient had received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) or measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose, route, lot# and expiration date were not reported) (wrong product administered). No additional adverse events were reported.
rash/ugly rash; itchy rash; This is a spontaneous report from a contactable consumer (patient). This 80-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 13Jan2021 for COVID-19 immunisation. Medical history included patient was allergic to a lot of medication. Concomitant medication was not reported. Patient received 1st dose of vaccine on 13Jan2021.  On 20Jan2021, the patient developed a rash: got red, breaks down to smaller rash, itchy rash, "ugly rash".  Patient said she had not added any new products to her diet and no changes in her life. Patient said she was allergic to a lot of medication, and she got rashes all the time. Patient said she had not had fever, shortness of breath or difficulty breathing. Only rash reported. Patient was asking if the rash could be from the vaccine since it didn't start "right after" getting her dose. It was made patient aware that some of the other reported experiences after vaccine were reported within 7 days of dose; made patient aware there was no way to confirm or deny if her rash was from vaccine. Referred patient to speak with HCP. Patient was inquiring about getting 2nd dose of vaccine after experiencing side effect after 1 dose.  Patient had already spoken with her PCP, who encouraged the 2nd dose. It was referred patient to speak with HCP before making any medical decisions; made patient aware the only contraindication at this time, to getting doses would be severe allergic reaction to ingredients/1st dose. The outcome of events was unknown.   Information on the lot/batch number has been requested.
Information has been received from a physician concerning a 10 year old female who on approximately 22-APR-2008 (a week ago) was vaccinated with a dose of GARDASIL, 0.5 mL. Concomitant medication was not reported. While in the physician's office, the patient experienced syncopal episode after receiving the GARDASIL. The outcome and causality of the event were not reported. Additional information has been requested.
dad took it every year and then would get sicker than a dog; Initial information regarding an unsolicited valid non-serious case received from a non-healthcare professional (patient's daughter) via social media on 28-Nov-2020 with live follow up on 08-Dec-2020. Both processed together.  This case involves a male patient who would get sicker than a dog (illness), after he receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient would get sicker than a dog (illness), (unknown latency) following the shot of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Mom states in the evening after receiving vaccines that morning, that the patient had vomiting and diarrhea with blood x 3 days.
pt recv vax;fever 103.2; rash, achy & swollen joints,especially fingers; HA, inc SGOT, SGPT,GGT & bili;sl jaundice;no liver tenderness,bili urine, severe lethargy;these sz lasted 7 days & then felt very well;
I have had blood pressure spikes and terrible arthritis ever sincemy Moderna booster..my Cardiologist keeps trying to find a script that will help with the spikes therse are the 5 I hve been on in the llast six months and my reactions 10/22 Cardevol 6.25 mg=pretty bad asthma attack almost had to go to emergency but I toughed it out,...11/22Verapamil. 40 mg.my legs swelled up like telephone poles and took me 6 week  or so of diruetics to get them back down. 2/23,Chlorathidone50 mg  4 days and my stools were pale yellow Obviously killing my liver...4/23. Doazosin mesylate.4 mg.so dizzy I couldnt walk down the  hall without  hands on the walls.5/23 Isosorbide Dinitrite 10 mg ONE dose gave me a horrid headache and doubled my arthritis pain..still dealing with  the arthritis 2 weeks later.  While I am sensative to  drugs I take several with NO side effects including Losartin Metoprolos Clonodine, Ventolin inhaler, no labs but you should be aware of my responses.
She ran a temperature for that 1st day; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (She ran a temperature for that 1st day) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced BODY TEMPERATURE INCREASED (She ran a temperature for that 1st day). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, BODY TEMPERATURE INCREASED (She ran a temperature for that 1st day) outcome was unknown.            No concomitant medications were reported   This case was linked to MOD-2021-366478 (Patient Link).
Redness; Itchiness; A spontaneous report was received on 3 Feb 2021, from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, itchiness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 2 Feb 2021, the patient experienced the event(s) redness, itchiness.  Treatment details included Tylenol rapid release gel cap, Hydrocortisone 1%.  Action taken with mRNA-1273 in response to the events was not reported.  On 4 Feb 2021 the outcome of event(s), redness, itchiness was resolved.
Pt was given vaccine after all DURs were verified. After vaccine patient stood and walked to waiting area with out issue. After 5-7 minutes patient lifted his arm getting our attention. Came out to patient were he said his vision was getting very blurry. Said he could not read the sign 6 feet in front of him. I touched his shoulder as a precaution and asked if he could see me. He stated yes and proceeded to put his head back and take down his mask and close his eyes. I asked pharmacy staff to call a code. His forehead and back of his neck were visibly wet from sweating. He moved his head forward and hung it down for 3 seconds before lifting it saying his vision was back. I asked if he had any blurriness or faintness still and he verbally said no. I asked if I could get some water for him and he said yes. I also gave him a granola bar and he said that it helped a lot. We also brought paper towel for his forehead and neck. He then stated that he hadn't eaten all day. He felt embarrassed that we had to call a code and get more people involved. His color came back 3-5 minutes after he initially lifted his head and said his vision was back. Pharmacy made pt sit another 15 minutes after his color came back. Watched patient stand up after the 15 minutes and pt said he felt good. Told patient we would be sending reports about what happened and if it was okay with him to provide his information to be contacted if needed, he agreed.
The E.M.T's said my wife was having a "mini stroke" but cat scan was negative so it must have been a seizure. My wife is now home recovering. She is still experiencing headaches and is lethargic
Patient was given Prevnar 13 and got Guillain-Barre syndrome; This is a spontaneous report from a contactable physician via a Pfizer sales representative. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient was given pneumococcal 13-val conj vac (dipht crm197 protein) and got guillain-barre syndrome on an unspecified date with outcome of unknown.; Sender's Comments: There is no plausible mechanism to establish a causal relationship between the occurrence of the event "guillain-barre syndrome" and the administration of the suspect vaccine in the individual case.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Pt received TRUMENBA in her left arm. Within 3 minutes she said she felt faint upon standing up. She wasn't dizzy. She had a syncopal episode and fell to the floor with her mother holding her. Her eyes rolled back. She was diaphoretic. She had a dystonic reaction where her arms, hands, legs, flexed and contorted. Within less than 1 minutes she was alert and coherent but pale and diaphoretic. Within 15 min was fully recovered.
14 spells lasting a few seconds each most between 8-9AM; consisting of arm flexion, arms trembling, strange facial grimace, eyes rolling back in between spells acting less alert & fussy;
Diarrhea; Major headache; Nausea; Body aches; low grade ever; Chills; A spontaneous report was received from a healthcare professional concerning a 71-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events major headache, nausea, body aches, low grade ever, diarrhea, chills.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 42L20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events major headache, nausea, body aches, low grade ever, diarrhea, chills.  Treatment information include,She did not take anything for her symptoms.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events, major headache, nausea, body aches, low grade ever, diarrhea, chills was unknown.
Rash all over body X 3 days, described as: SKIN: raised erythematous circular lesions, some with central clearing covering trunk and extremities.
Pt. seen at ER on 12/2/10 for a rash. Pt. started with hives on 12/1/10. No SOB/wheezing. No itching. No upper respiratory symptoms, cough, or fever. No vomiting or diarrhea. No treatment necessary. Pt. was discharged to home to follow-up with Allergy clinic.
About 11 days after the vaccination started to feel like I had earache, runny nose and ear felt full and was hurting the next week I tried treating at home with over the counter meds and I end up going to the doctor because I was feeling dizzy and I was told I had a head cold.
Mom was aware that her daughter doesn't do well with needles. Her dad is the same way, per mom. Patient fainted in the immunization room. We gave her a granola bar and some water before the injection, as a preventative measure. She fainted a second time. Mom checker her BP and patient felt nauseous. She started jerking and 911 was called. EMTs said it was not a seizure, but a vasovagal jerk. Paramedics said to lay the person down after the patient started jerking. When she was stable enough to be moved, EMTs wheeled her to the door of the store.
Right arm swollen, red and very painful to move or touch. Apply ice pack off and on for 24 hrs.
On 08/12/202, started with a bad headache and I started feeling bad all over. On 08/16/2021. I was tested for COVID-19  the results were positive. At that time I had these symptoms: I could not walk, eat, lost my sense of smell and taste, not sleeping right, and hallucinations, On Thursday, 08/26/2021 I went to the ER and they gave me some medicine and sent me home. On 08/30/2021, I ended up in the hospital. I was in the hospital for 5 days. They gave me an antiviral medication through an IV and some antibiotics.  I was on low dose oxygen. When I went into the hospital, I also had a UTI. I was still testing positive after 2 weeks for COVID-19. They gave me medicine and they got rid of the UTI.  And they sent me home on Saturday, 09/04/2021. I have not recovered from my AEs, I am still not sleeping well , still have congestion, fatigue, not walking right, having a hard time breathing at times.
pt devel a limp in rt leg 1 day p/vax;pt exp no impairment of activities;
Cough; chest congestion; Nasal congestion; This is a spontaneous report from a contactable healthcare professional, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: AW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 23-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 22:00, the patient experienced cough, chest congestion and nasal congestion. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events cough, chest congestion and nasal congestion were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 39 years, in right arm for COVID-19 immunization; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 12Nov2021 as dose number unknown, single (Batch/Lot number: unknown), in right arm for COVID-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown). The patient's relevant medical history included: "Chronic fatigue" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Ptsd" (unspecified if ongoing); "Pcos" (unspecified if ongoing); "Acid reflux" (unspecified if ongoing); "Ibs (combat veteran)" (unspecified if ongoing); "Known allergies: penicillin" (unspecified if ongoing); "Known allergies: Lemon" (unspecified if ongoing); "Known allergies: Lime" (unspecified if ongoing); "Known allergies: Ginger" (unspecified if ongoing); "Known allergies: Thyme" (unspecified if ongoing); "Known allergies: Oregano" (unspecified if ongoing); "Known allergies: Basil" (unspecified if ongoing); "Known allergies: Some tree nuts" (unspecified if ongoing); "Known allergy:Sulfa" (unspecified if ongoing). Concomitant medication(s) included: PEPCID AC; DESLORATADINE, start date: 01Mar2022. Past drug history included: Known allergies: pseudoephedrine, reaction(s): "Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of suspected covid-19, covid-19. Patients Anti-viral details: Treatment start date-13May2022 treatment stop date-18May2022.  The information on the batch/lot number for (BNT162B2), has been requested and will be submitted if and when received.
Extreme Fatigue, headache, body aches, nausea, flu like symptoms, incapacitated for 31.5 hours, starting 7.5 hours after 2nd Moderna Covid 19 vaccine injection dosage was administered. Only injection site pain after first vaccine.
No additional AE reported; a dose of PNEUMOVAx 23 expired on 10/3/2021 and was administered on 10/5/2021; This spontaneous report was received from a nurse referring to a patient of unknown age or gender. No information regarding the patient's pertinent medical history, concomitant medication, previous drug reactions, or allergies was provided.  On 05-OCT-2021, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) (lot number T021329 has been verified to be valid as vial formulation, expiration date reported and validated as 03-OCT-2021), at a dose of 0.5 milliliter (dose number, vaccination scheme, route of administration, and anatomical location of administration were not reported) as prophylaxis (expired product administered). No additional adverse events (AE) were reported.
Sick to my stomach all day next day and finally threw up at 3:30 AM on April 24th and felt better after that. However April 25th/26th I stated to break out with blisters on my body. I found two. One on the inside of my right thigh and one on my lower back. They look like shingles. NOT HAPPY.
Initial report was received 18 October 2011 from a health care professional. A female patient (age not reported) had received an injection of FLUZONE High-Dose (lot number, route, site and date of administration not reported) and an unspecified amount of time later, the patient developed cellulitis. Outcome was not reported. No additional information was provided at the time of the report. Follow-up information was received from a health care professional on 18 November 2011 reported that the patient had no illnesses at the time of vaccination. The outcome was reported as recovered. Follow-up information received from a nurse on 20 December 2011. The patient who was an 84-year-old female required antibiotic therapy for the cellulitis at the injection site. No other relevant medical information was provided. Coding was amended to "vaccination site cellulitis" from just "cellulitis" as the cellulitis was confirmed to be at the injection site. Documents held by sender: None.
Upper lip swelled up and felt real strange. Patient went to ER. By the time she got there the swelling subsided.
I had horrible flu like symptoms. Back pains, nausea, body aches. I had a heart attack 01/14/2021. Since then I've had heart failure, mini stroke (04/2021), high blood pressure.
Client received 2nd dose COVID vaccine at approximately 11 am, complained of nausea and dizziness @ 11:23 am.  Client placed in zero gravity chair, vital signs stable.  Client reports same symptoms with 1st COVID vaccine, less severe symptoms this time.  Vitals remained stable, symptoms resolved @ 11:49 am.  Client went home with friend, walking with steady gait.